Delivery Order SPE2DB20D3104-SPE2DB24FV7P6

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,136.36 firm fixed-price delivery order is for the supply of Enbrel 50 mg/mL syringes. The contract has an ultimate completion date of November 22, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,165.94, is a Firm Fixed Price Delivery Order for the supply of ENBREL 50 MG/ML SYRINGEML. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is a delivery order valued at $14,180.78 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Enbrel 50 mg/mL syringes and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a wide range of pharmaceutical...
This federal contract award, valued at $51,819.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,304.28 firm fixed-price delivery order contract is for the supply of ENBREL 50 MG/ML syringes. This award is not designated with a set-aside and represents open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,199.27 delivery order is for the supply of Enbrel 50 mg/mL syringes, a biologic drug used to treat autoimmune conditions. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENBREL 25 MG/0.5 ML SYRINGE 0.5ML. The firm-fixed-price delivery order, valued at $4,178.14, has a completion date of June 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides $66,490.81 for the delivery of the drug Enbrel (50 mg/mL) to the Defense Logistics Agency (DLA) Troop Support Medical. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999 through December 2025, for a wide range of medical commodities to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,061.71 Firm Fixed Price delivery order covers the supply of ENBREL 50 MG/ML SYRINGEML, a specialty medication. The contract has an ultimate completion date of August 28, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,152.14 firm fixed price delivery order is for Enbrel 50 mg/mL syringes and has a completion date of May 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB24FV7P6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $16,608.56 Firm Fixed Price delivery order is for the supply of Enbrel 50 mg/ml syringes.

Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This IDC enables the DLA to efficiently procure essential medical commodities for military treatment programs and facilities globally.

The contract award does not have a set-aside designation, indicating it was competed on a full and open basis. Amerisourcebergen's proven expertise in pharmaceutical distribution and supply chain management likely contributed to its selection for this and other federal contracts.

Generated 9/16/24, 10:34 AM